ABT Molecular Imaging
Louisville, US
Founders & leadership
RN
Ronald NuttFounder
TE
Thomas E WelchExecutive
RA
Robert A VincillExecutive
Board
DD
Dennis DoughertyBoard director
BL
Bengt LangstromBoard director
Reported raises · per SEC filings
Form D private placements$3.3M disclosed across 5 rounds · 2012–2014
▶$750KraisedAug 2014 · 3 investors · BiotechnologyRule 506(b)
▶$750KraisedAug 2014 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael TemplinExecutive Officer
- Peter KingmaExecutive Officer, Director
- Dennis DoughertyDirector
- Rik VandevenneDirector
- Offering amount
- $1.3M
- Amount sold
- $750K
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$775KraisedMay 2014 · 3 investors · BiotechnologyRule 506(b)
▶$775KraisedMay 2014 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dennis DoughertyDirector
- Peter KingmaExecutive Officer, Director
- Michael TemplinExecutive Officer
- Rik VandevenneDirector
- Offering amount
- $1.1M
- Amount sold
- $775K
- First sale
- May 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$800KraisedApr 2014 · 3 investors · BiotechnologyRule 506(b)
▶$800KraisedApr 2014 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael TemplinExecutive Officer
- Rik VandevenneDirector
- Dennis DoughertyDirector
- Peter KingmaExecutive Officer, Director
- Offering amount
- $1.1M
- Amount sold
- $800K
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedFeb 2014 · 3 investors · BiotechnologyRule 506(b)
▶$500KraisedFeb 2014 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael TemplinExecutive Officer
- Dennis DoughertyDirector
- Ronald NuttDirector
- Rik VandevenneDirector
- Peter KingmaExecutive Officer, Director
- Offering amount
- $685.8K
- Amount sold
- $500K
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedMar 2012 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedMar 2012 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dennis DoughertyDirector
- Ronald NuttDirector
- Thomas E WelchExecutive Officer, Director
- Robert A VincillExecutive Officer
- Bengt LangstromDirector
- Offering amount
- $500K
- Amount sold
- $500K
- Minimum investment
- $500K
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $222.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded ABT Molecular Imaging?
- ABT Molecular Imaging was founded by Ronald Nutt.
- How much funding has ABT Molecular Imaging raised?
- ABT Molecular Imaging has disclosed $3.3M raised across 5 rounds.
- Where is ABT Molecular Imaging headquartered?
- ABT Molecular Imaging is headquartered in Louisville, US.